Carl Soltau

Mr Carl Soltau is a medicinal chemist focused on developing novel therapeutic strategies and understanding the mechanisms required to address major challenges in preserving human health. He obtained his PhD in 2026 from the Queensland University of Technology, where his research has centred on the design and synthesis of nitroxide-based hybrid molecules with mutiple modes of action, including anti-inflammatory, and anticancer activity. In his current current role, he focus on the synthesis of fluorescent antibiotic derivatives as to better understand drug–target interactions, localisation, and mechanisms of resistance in bacterial systems.

Overall, his research is driven by a broader goal of uncovering how molecular design can be leveraged to better understand and overcome complex disease processes.